These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25677951)

  • 1. Chemistry and biology of tubulysins: antimitotic tetrapeptides with activity against drug resistant cancers.
    Murray BC; Peterson MT; Fecik RA
    Nat Prod Rep; 2015 May; 32(5):654-62. PubMed ID: 25677951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified pretubulysin derivatives and their biological effects on cancer cells.
    Kubisch R; von Gamm M; Braig S; Ullrich A; Burkhart JL; Colling L; Hermann J; Scherer O; Müller R; Werz O; Kazmaier U; Vollmar AM
    J Nat Prod; 2014 Mar; 77(3):536-42. PubMed ID: 24437936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tubulin-bound structure of the antimitotic drug tubulysin.
    Kubicek K; Grimm SK; Orts J; Sasse F; Carlomagno T
    Angew Chem Int Ed Engl; 2010 Jun; 49(28):4809-12. PubMed ID: 20496362
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in the synthesis of tubulysins.
    Xiangming X; Friestad GK; Lei Y
    Mini Rev Med Chem; 2013 Oct; 13(11):1572-8. PubMed ID: 23746060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
    Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
    J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo structural activity and optimization studies of folate-tubulysin conjugates.
    Reddy JA; Dorton R; Dawson A; Vetzel M; Parker N; Nicoson JS; Westrick E; Klein PJ; Wang Y; Vlahov IR; Leamon CP
    Mol Pharm; 2009; 6(5):1518-25. PubMed ID: 19630399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total syntheses of tubulysins.
    Shibue T; Hirai T; Okamoto I; Morita N; Masu H; Azumaya I; Tamura O
    Chemistry; 2010 Oct; 16(38):11678-88. PubMed ID: 20734394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents.
    Lai MJ; Kuo CC; Yeh TK; Hsieh HP; Chen LT; Pan WY; Hsu KY; Chang JY; Liou JP
    ChemMedChem; 2009 Apr; 4(4):588-93. PubMed ID: 19266513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of tubulysin analogues.
    Courter JR; Hamilton JZ; Hendrick NR; Zaval M; Waight AB; Lyon RP; Senter PD; Jeffrey SC; Burke PJ
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127241. PubMed ID: 32527543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship studies of novel tubulysin U analogues--effect on cytotoxicity of structural variations in the tubuvaline fragment.
    Shankar SP; Jagodzinska M; Malpezzi L; Lazzari P; Manca I; Greig IR; Sani M; Zanda M
    Org Biomol Chem; 2013 Apr; 11(14):2273-87. PubMed ID: 23411563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Total Synthesis of Tubulysins and Design, Synthesis, and Biological Evaluation of New Tubulysins with Highly Potent Cytotoxicities against Cancer Cells as Potential Payloads for Antibody-Drug Conjugates.
    Nicolaou KC; Erande RD; Yin J; Vourloumis D; Aujay M; Sandoval J; Munneke S; Gavrilyuk J
    J Am Chem Soc; 2018 Mar; 140(10):3690-3711. PubMed ID: 29381062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7,11-epi-thyrsiferol: completion of its synthesis, evaluation of its antimitotic properties, and the further development of an SAR model.
    Nishiguchi GA; Graham J; Bouraoui A; Jacobs RS; Little RD
    J Org Chem; 2006 Aug; 71(16):5936-41. PubMed ID: 16872175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Cytotoxicity Relationships of Analogues of N
    Toader D; Wang F; Gingipalli L; Vasbinder M; Roth M; Mao S; Block M; Harper J; Thota S; Su M; Ma J; Bedian V; Kamal A
    J Med Chem; 2016 Dec; 59(23):10781-10787. PubMed ID: 27809515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines.
    Ouyang X; Piatnitski EL; Pattaropong V; Chen X; He HY; Kiselyov AS; Velankar A; Kawakami J; Labelle M; Smith L; Lohman J; Lee SP; Malikzay A; Fleming J; Gerlak J; Wang Y; Rosler RL; Zhou K; Mitelman S; Camara M; Surguladze D; Doody JF; Tuma MC
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1191-6. PubMed ID: 16377187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis of tubulysin U and its C-4 epimer.
    Yang XD; Dong CM; Chen J; Ding YH; Liu Q; Ma XY; Zhang Q; Chen Y
    Chem Asian J; 2013 Jun; 8(6):1213-22. PubMed ID: 23576385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Synthesis and Biological Evaluation of Natural and Designed Tubulysins.
    Nicolaou KC; Yin J; Mandal D; Erande RD; Klahn P; Jin M; Aujay M; Sandoval J; Gavrilyuk J; Vourloumis D
    J Am Chem Soc; 2016 Feb; 138(5):1698-708. PubMed ID: 26829208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of antimitotic polyalkoxyphenyl derivatives of combretastatin using plant allylpolyalkoxybenzenes.
    Semenov VV; Kiselyov AS; Titov IY; Sagamanova IK; Ikizalp NN; Chernysheva NB; Tsyganov DV; Konyushkin LD; Firgang SI; Semenov RV; Karmanova IB; Raihstat MM; Semenova MN
    J Nat Prod; 2010 Nov; 73(11):1796-802. PubMed ID: 21049975
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues.
    Nieman JA; Coleman JE; Wallace DJ; Piers E; Lim LY; Roberge M; Andersen RJ
    J Nat Prod; 2003 Feb; 66(2):183-99. PubMed ID: 12608848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel potent antimitotic heterocyclic ketones: synthesis, antiproliferative activity, and structure-activity relationships.
    Hu L; Jiang JD; Qu J; Li Y; Jin J; Li ZR; Boykin DW
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3613-7. PubMed ID: 17482458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity and high-content imaging analyses of novel tubulysins.
    Wang Z; McPherson PA; Raccor BS; Balachandran R; Zhu G; Day BW; Vogt A; Wipf P
    Chem Biol Drug Des; 2007 Aug; 70(2):75-86. PubMed ID: 17683369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.